Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Statistics

Total Valuation

TSX:CTX has a market cap or net worth of CAD 8.68 million. The enterprise value is 1.10 million.

Market Cap	8.68M
Enterprise Value	1.10M

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CTX has 18.87 million shares outstanding. The number of shares has decreased by -3.82% in one year.

Current Share Class	18.87M
Shares Outstanding	18.87M
Shares Change (YoY)	-3.82%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	13.30%
Owned by Institutions (%)	0.80%
Float	16.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.56
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	6.76
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.82
EV / Sales	0.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.01

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.04.

Current Ratio	2.60
Quick Ratio	1.72
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-4.39
Interest Coverage	-33.19

Financial Efficiency

Return on equity (ROE) is -8.12% and return on invested capital (ROIC) is -6.50%.

Return on Equity (ROE)	-8.12%
Return on Assets (ROA)	-5.00%
Return on Invested Capital (ROIC)	-6.50%
Return on Capital Employed (ROCE)	-11.33%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.90
Inventory Turnover	1.91

Taxes

Income Tax	-14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.98% in the last 52 weeks. The beta is 1.18, so TSX:CTX's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	-26.98%
50-Day Moving Average	0.48
200-Day Moving Average	0.54
Relative Strength Index (RSI)	44.82
Average Volume (20 Days)	20,185

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CTX had revenue of CAD 20.27 million and -1.33 million in losses. Loss per share was -0.07.

Revenue	20.27M
Gross Profit	10.53M
Operating Income	-1.79M
Pretax Income	-1.35M
Net Income	-1.33M
EBITDA	-833,000
EBIT	-1.79M
Loss Per Share	-0.07

Balance Sheet

The company has 8.18 million in cash and 602,000 in debt, giving a net cash position of 7.58 million or 0.40 per share.

Cash & Cash Equivalents	8.18M
Total Debt	602,000
Net Cash	7.58M
Net Cash Per Share	0.40
Equity (Book Value)	15.61M
Book Value Per Share	0.83
Working Capital	9.70M

Cash Flow

In the last 12 months, operating cash flow was 1.28 million and capital expenditures -1.42 million, giving a free cash flow of -137,000.

Operating Cash Flow	1.28M
Capital Expenditures	-1.42M
Free Cash Flow	-137,000
FCF Per Share	-0.01

Margins

Gross margin is 51.98%, with operating and profit margins of -8.84% and -6.57%.

Gross Margin	51.98%
Operating Margin	-8.84%
Pretax Margin	-6.64%
Profit Margin	-6.57%
EBITDA Margin	-4.11%
EBIT Margin	-8.84%
FCF Margin	n/a

Dividends & Yields

TSX:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.82%
Shareholder Yield	n/a
Earnings Yield	-15.35%
FCF Yield	-1.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CTX has an Altman Z-Score of -0.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.67
Piotroski F-Score	3